Citius Pharmaceuticals Cultura da Companhia

Mr. Jaime Bartushak has been the Chief Financial Officer of Citius Pharmaceuticals, Inc. since November 27, 2017. Mr. Bartushak founded Leonard-Meron Biosciences, Inc. and served as its Chief Financial Officer, Executive Vice President and Treasurer since March 30, 2016. Mr. Bartushak is an experienced finance professional for early stage pharmaceutical companies and has over 20 years of corporate finance, business development, restructuring and strategic planning experience. Mr. Bartushak was one of the founders of LMB in 2014 and was instrumental in its startup as well as in obtaining initial investment capital. Prior to his work at LMB, in 2014 Mr. Bartushak helped lead the sale of PreCision Dermatology, Inc. to Valeant Pharmaceuticals International, Inc. He served as a Director of Leonard-Meron Biosciences, Inc. since March 30, 2016.

Mr. Leonard L. Mazur has been Chairman and Secretary at Citius Pharmaceuticals, Inc. since March 30, 2016. Mr. Mazur served as the Chief Executive Officer, President and Chief Operating Officer of Citius Pharmaceuticals, Inc. from September 12, 2014 to April 4, 2016. He co-founded Akrimax Pharmaceuticals in 2007. He Co-founded Triax Pharmaceuticals, LLC and served as its Chief Operating Officer from January 2005 to May 2012. He began his pharmaceutical career with Cooper Laboratories, Inc. in 1971, where he served as a Product Manager for ophthalmology, dermatology and other products. He was responsible for creating and growing the business that was sold to Pierre Fabre, a French dermatology company, in 2002. In 1995, he founded Genesis Pharmaceutical, Inc., and served as its Chairman, Chief Executive Officer from 1995 to 2005 and President. In 1989, he became one of the first employees of Medicis Pharmaceuticals Corporation, a start-up dermatology pharmaceuticals company. Mr. Mazur was responsible for acquiring brands, as well as sales and marketing. He was promoted to Marketing Manager with responsibility for the ethical OTC division where he managed sales and licensing. He served as Vice President of Sales & Marketing, Knoll Pharma (a division of BASF) and Cooper Laboratories, Inc. In 1984, he joined ICN Pharmaceuticals as Vice President of Marketing and Sales and managed all aspects of the US pharmaceuticals group, including marketing, sales, licensing and acquisitions. In 1981, he joined Knoll Pharmaceuticals as Director of Product Management. After a 2-year transition period, Mr. Mazur joined Krivulka in founding Triax. He serves as a Vice Chairman of Akrimax Pharmaceuticals, Llc. He serves as a Member of Life Sciences & Healthcare Advisory Board at JRG Ventures, LLC. He has been a Director of Citius Pharmaceuticals, Inc. since September 12, 2014. He served as a Director of PhotoMedex, Inc. since May 13, 2009. He is a member of the Board of Trustees of Manor College and is a recipient of the Ellis Island Medal of Honor. Mr. Mazur received both his BA and MBA from Temple University and has served in the U.S. Marine Corps Reserves.

Mr. Gary F. Talarico serves as an Executive Vice President of Operations of Citius Pharmaceuticals, Inc. Mr. Talarico has more than 20 years of marketing and sales experience within the pharmaceutical industry. He served as an Executive Vice President of Operations at Leonard-Meron Biosciences, Inc. since March 30, 2016. He served as a Senior Vice President and Senior Vice President of Sales of Triax Pharmaceuticals, LLC. He served as Vice President of Sales of Dusa Pharmaceuticals Inc., from February 2005 to July 22, 2005 and served as a Member of Management Team since February 2005. Mr. Talarico, a senior, experienced sales professional with a significant background in dermatology and a track record of generating strong sales growth as DUSA continues to gear up for increasing adoption of its Levulan(R) Photodynamic Therapy (PDT). He served as an Executive Vice President of Sales and Marketing for Reliant Pharmaceuticals, where he built the sales force from start-up to over 800 sales professionals while bringing seven products to market. He served as the Chief Scientific Officer and Executive Vice President of Business Development for Ventiv Health US Sales. He has extensive background in dermatology having served as Vice President of Dermatology at Cabot Laboratories and Vice President of Sales at Medicis Pharmaceuticals, where he built its field sales team and supporting infrastructure and launched its first products. He began his pharmaceutical career as a Full Line Sales Representative and quickly progressed to Hospital Representative, District Manager, Training Manager and Regional Manager. In 1984, he joined ICN Pharmaceuticals, Inc. where, as Director of Sales, he built a newly created hospital sales force and reengineered ICN's Dermatology sales team. In 2003, he formed GTInsights to provide consulting services to pharmaceutical manufacturers and pharmaceutical industry service companies.